1 / 8

Medical Bionics Market to Reach $29,160 Million, Globally, by 2023

Bionic eye segment is projected to grow at a CAGR of 13.9% during the forecast period. Implantable bionics accounted for more than four-fifths share of the global medical bionics market. Exoskeleton segment is expected to register the highest CAGR of 21.0% during the analysis period owing to the increasing number of amputees.France and Germany jointly contributed for nearly one-fourth of the European medical bionics market in 2015.<br>

srushtih123
Download Presentation

Medical Bionics Market to Reach $29,160 Million, Globally, by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Medical Bionics Market Key Players : Abbott, Boston Scientific Corporation, Cochlear Ltd., LivaNova PLC Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Medical Bionics Market “Technological advancement is one factor that majorly drives the growth of medical bionics market. Newer development in the heart treatment field feature technologically advanced tissue heart valves useful in heart valve repair and replacement. Further, with the advent of tissue valves used in tissue aortic valve replacement, the quality of life for patients suffering from aortic regurgitation has improved.”

  3. Medical Bionics Market Overview Medical Bionics Market Report, published by Allied Market Research, forecasts that the global market was valued at $15,348 million in 2016, and is expected to garner $29,160 million by 2023, registering a CAGR of 9.6% during the forecast period 2017 - 2023. Cardiac bionics segment held more than one-third share of the total market in 2016. Access Full Summary at: https://www.alliedmarketresearch.com/medical-bionics-market Bionics are the implantable devices, which imitates the function of a natural organ. Advent of technologically advanced systems such as cochlear implants and rise in incidence of chronic disease majorly drive the market growth. 

  4. Medical Bionics Market This region offers lucrative opportunities in this market owing to presence of large pool of patients suffering from chronic disorders such as cardiac disorders, neural disorders and hearing and vision loss. In 2011, the Australian Institute of Health & Welfare estimated that at least 300,000 Australians have suffered from chronic heart failure and 30,000 new cases are identified every year. Hence, high incidence of cardiac disorders makes it an attractive market for cardiac bionics. In addition, high prevalence of eye-related diseases in Japan makes it an attractive market for eye bionics in the country.  As per the estimates of the annual report (2014) published by the American Heart Association in Heart Ware International, Inc., approximately 5.5 million individuals are affected by heart failure in the U.S. Moreover, approximately 670,000 new cases of heart failure are diagnosed each year in the U.S. Similarly, in Canada there is a rise in the prevalence of chronic diseases due to unhealthy lifestyle and aging population.

  5. Medical Bionics Market, Snapshot The field of medical bionics have witnessed several technological advancements in the recent years. The cochlear implants available in the present scenario have speech recognition in difficult listening situations, which help to differentiate speech in noisy and reverberant situation, understand sound from television or telephone, and identify a sound from distance.   The key companies operating in the medical bionics market are Abbott, Boston Scientific Corporation, Cochlear Ltd., LivaNova PLC, Medtronic plc, Orthofix Holdings, Inc., ssur Corporate, Retina Implant AG, Sonova, SECOND SIGHT, SynCardia Systems, LLC, and William Demant Holding A/S

  6. Key Benefits Medical Bionics Market • The study provides an in-depth analysis of the global medical bionics market, with current trends and future estimations, to elucidate the imminent investment pockets. • Quantitative analysis from 2016 to 2023 is expected to enable the stakeholders to capitalize on prevailing market opportunities. • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities. • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework. 

  7. Medical Bionics Market North America Europe Asia-Pacific LAMEA

  8. Medical Bionics Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/2171 Follow Us On

More Related